Jay Newmark
Chief Tech/Sci/R&D Officer chez CLARUS THERAPEUTICS HOLDINGS, INC.
Profil
Jay Newmark is currently the Chief Medical Officer at Clarus Therapeutics Holdings, Inc. He previously worked as the Senior Director-Medical Affairs at Genomic Health, Inc. and OPKO Health, Inc. He also served as the Chief Medical Officer at Blue Water Biotech, Inc. and Clarus Therapeutics, Inc. Dr. Newmark holds an MBA degree from The University of Chicago and a doctorate degree from the University of Michigan Medical School.
Postes actifs de Jay Newmark
Sociétés | Poste | Début |
---|---|---|
CLARUS THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Jay Newmark
Sociétés | Poste | Fin |
---|---|---|
GENOMIC HEALTH, INC. | Corporate Officer/Principal | 01/08/2019 |
OPKO HEALTH, INC. | Corporate Officer/Principal | 01/04/2018 |
Blue Water Biotech, Inc.
Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Chief Tech/Sci/R&D Officer | - |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Chief Tech/Sci/R&D Officer | - |
Formation de Jay Newmark
The University of Chicago | Masters Business Admin |
University of Michigan Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
OPKO HEALTH, INC. | Health Services |
CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
Blue Water Biotech, Inc.
Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Health Technology |